Q2 2020 Medivir AB Earnings Call Transcript
Ladies and gentlemen, welcome to the Medivir AB Q2 report 2020. (Operator Instructions)
Today, I am pleased to present Uli Hacksell, CEO. Please begin your meeting.
()-
Thank you, and good afternoon. With me today are Magnus Christensen, who is the Chief Financial Officer; and Linda Basse, our Chief Medical Officer. With that, I will start out by asking Magnus to provide a financial summary of the second quarter.
()-
Thank you, Uli. Please see Slide 3, where you can see the financial summary. You can see the summary for quarter 2 and the half year-end of June. And you can see the turnover for quarter 2 amounts to SEK 4 million, which is very similar to last year and relates to royalty income from Xerclear. Accumulated for the first 6 months of 2020 is SEK 11.4 million, this is almost double last year and it relates to both higher royalty income from Xerclear as well as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
